The Wilms' Tumor Gene Product WT1 Mediates the Down-regulation of the Rat Epidermal Growth Factor Receptor by Nerve Growth Factor in PC12 Cells
Open Access
- 1 February 2001
- journal article
- Published by Elsevier
- Vol. 276 (7) , 5068-5073
- https://doi.org/10.1074/jbc.m008776200
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cloning and Characterization of the Promoter Region of the Rat Epidermal Growth Factor Receptor Gene and Its Transcriptional Regulation by Nerve Growth Factor in PC12 CellsPublished by Elsevier ,2000
- The Wilms' Tumor 1 Gene: Oncogene or Tumor Suppressor Gene?Published by Elsevier ,1998
- The WT1 Protein Is a Negative Regulator of the Normalbcl-2 Allele in t(14;18) LymphomasJournal of Biological Chemistry, 1997
- A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1.Proceedings of the National Academy of Sciences, 1993
- Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumpingNature, 1990
- Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locusCell, 1990
- Long-term, heterologous down-regulation of the epidermal growth factor receptor in PC12 cells by nerve growth factor.The Journal of cell biology, 1987
- PC12 cell mutants that possess low- but not high-affinity nerve growth factor receptors neither respond to nor internalize nerve growth factor.The Journal of cell biology, 1986
- Nerve growth factor-induced alteration in the response of PC12 pheochromocytoma cells to epidermal growth factorThe Journal of cell biology, 1981
- Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.Proceedings of the National Academy of Sciences, 1976